Worldwide CAR T-Cell Therapy Industry to 2030 - Players Include Legend Biotech, Novartis & Pfizer Among Others
Share this article Share this article ResearchAndMarkets.coms offering. The scientific community has been pursuing research for the development of CAR T-cell therapy for over a century. Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patients immune system to attack cancer. The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030. The market is driven by certain factors, which include incre...
United States South Korea Brexucabtagene Autoleucel Tecartus Axicabtagene Ciloleucel Tisagenlecleucel Kymriah Idecaptagene Cicleucel
Source: prnewswire.com